The road to romiplostim approval and beyond.
Publication
, Journal Article
Lyman, GH
Published in: Oncology (Williston Park)
July 2009
Duke Scholars
Published In
Oncology (Williston Park)
ISSN
0890-9091
Publication Date
July 2009
Volume
23
Issue
8
Start / End Page
709 / 715
Location
United States
Related Subject Headings
- Thrombopoietin
- Recombinant Fusion Proteins
- Receptors, Fc
- Purpura, Thrombocytopenic, Idiopathic
- Humans
- Carrier Proteins
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H. (2009). The road to romiplostim approval and beyond. Oncology (Williston Park), 23(8), 709–715.
Lyman, Gary H. “The road to romiplostim approval and beyond.” Oncology (Williston Park) 23, no. 8 (July 2009): 709–15.
Lyman GH. The road to romiplostim approval and beyond. Oncology (Williston Park). 2009 Jul;23(8):709–15.
Lyman, Gary H. “The road to romiplostim approval and beyond.” Oncology (Williston Park), vol. 23, no. 8, July 2009, pp. 709–15.
Lyman GH. The road to romiplostim approval and beyond. Oncology (Williston Park). 2009 Jul;23(8):709–715.
Published In
Oncology (Williston Park)
ISSN
0890-9091
Publication Date
July 2009
Volume
23
Issue
8
Start / End Page
709 / 715
Location
United States
Related Subject Headings
- Thrombopoietin
- Recombinant Fusion Proteins
- Receptors, Fc
- Purpura, Thrombocytopenic, Idiopathic
- Humans
- Carrier Proteins